Search
InMed Pharmaceuticals Inc
INMAdd to Watchlist
1.460USD
-0.040-2.67%
Close 07-31 16:00（ET）Quotes delayed by 15 min
4.09MMarket Cap
LossP/E TTM
INM Financials
See InMed Pharmaceuticals Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.
InMed Pharmaceuticals Inc Earnings Date
Latest Release
May 6, 2026
EPS / Forecast
--/--
Revenue / Forecast
--/--
Period
FY2025 Earnings
Revenue(YoY)
4.94M
7.50%
EPS(YoY)
-8.36
58.48%
Analyst Rating
--
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FAQs
What is the total revenue of InMed Pharmaceuticals Inc?
According to InMed Pharmaceuticals Inc's FY2025 earnings report, its total revenue reached 4.94M, with a year-on-year change of 4.60M.
What are the current assets of InMed Pharmaceuticals Inc?
According to InMed Pharmaceuticals Inc's FY2025 earnings report, its current assets were 12.87M, with a year-on-year change of 48.08.
What are the total assets of InMed Pharmaceuticals Inc?
According to InMed Pharmaceuticals Inc's FY2025 earnings report, its total assets of InMed Pharmaceuticals Inc were 15.58M, with a year-on-year change of 31.78.
What are the total liabilities of InMed Pharmaceuticals Inc?
According to InMed Pharmaceuticals Inc's FY2025 earnings report, its total liabilities of InMed Pharmaceuticals Inc were 2.15M, with a year-on-year change of -18.00.
What is the total equity of InMed Pharmaceuticals Inc?
According to InMed Pharmaceuticals Inc's FY2025 earnings report, its total equity of InMed Pharmaceuticals Inc was 13.43M, with a year-on-year change of 45.93.
What is the net operating income of InMed Pharmaceuticals Inc?
According to InMed Pharmaceuticals Inc's FY2025 earnings report, its net operating income of InMed Pharmaceuticals Inc was -7.92M, with a year-on-year change of 2.66.
What is the net financing of InMed Pharmaceuticals Inc?
According to InMed Pharmaceuticals Inc's FY2025 earnings report, its net financing of InMed Pharmaceuticals Inc was 12.27M, with a year-on-year change of 163.66.
What is the Earnings Per Share (EPS) of InMed Pharmaceuticals Inc?
According to InMed Pharmaceuticals Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -8.36, with a year-on-year change of 58.48.
What is the net income of InMed Pharmaceuticals Inc?
According to InMed Pharmaceuticals Inc's FY2025 earnings report, its net income was -8.16M, with a year-on-year change of -6.34.
What is the net margin of InMed Pharmaceuticals Inc?
According to InMed Pharmaceuticals Inc's FY2025 earnings report, its net profit margin was -165.14, with a year-on-year change of 1.08.
What is the gross margin of InMed Pharmaceuticals Inc?
According to InMed Pharmaceuticals Inc's FY2025 earnings report, its gross margin was 30.22, with a year-on-year change of 57.66.
What is the Return on Equity (ROE) of InMed Pharmaceuticals Inc?
According to InMed Pharmaceuticals Inc's FY2025 earnings report, its Return on Equity (ROE) was -72.10, with a year-on-year change of -0.02.
What is the Return on Assets (ROA) of InMed Pharmaceuticals Inc?
According to InMed Pharmaceuticals Inc's FY2025 earnings report, its Return on Assets (ROA) was -59.57, with a year-on-year change of -0.62.
What is the operating profit of InMed Pharmaceuticals Inc?
According to InMed Pharmaceuticals Inc's FY2025 earnings report, its operating profit was -7.92M, with a year-on-year change of 2.66.